Table III.

Assay results

		Number of positive samples; days after inoculation
Pathogen	Sample type	1	2	4	6	8	9	11	13	14	15	17	21	23	28	Totals
PRRSV VR-2332	Aerosol	ns	ns	ns	0	0	ns	0	0	ns	0	ns	ns	ns	ns	0/100
PRRSV VR-2385	Aerosol	0	ns	0	ns	0	ns	0	0	ns	0	ns	ns	ns	ns	0/36
PCV-2	Aerosol	0	0	ns	0	0	ns	ns	ns	0	ns	ns	ns	ns	ns	0/20
PRCoV	Aerosol	ns	0	0	0	0	0	ns	ns	ns	ns	ns	ns	ns	ns	0/20
SIV	Aerosol	ns	0	0	ns	0	0	ns	ns	ns	ns	ns	ns	ns	ns	0/16
M. hyopneumoniae	Aerosol	0	ns	0	0	1	ns	0	ns	0	0	1	1	0	1	4/44
B. bronchiseptica	Aerosol	ns	0	0	2	0	0	ns	ns	ns	ns	ns	ns	ns	ns	2/20
PRRSV VR-2332	Oral swab	ns	ns	ns	10	5	ns	6	6	ns	2	ns	ns	ns	ns	29/100
PRRSV VR-2385	Oral swab	0	ns	4	ns	1	ns	2	0	ns	0	ns	ns	ns	ns	7/36
PCV-2	Nasal swab	0	0	ns	0	0	ns	ns	ns	3	ns	ns	ns	ns	ns	3/20
PRCV	Nasal swab	ns	3	2	2	0	0	ns	ns	ns	ns	ns	ns	ns	ns	7/20
SIV	Nasal swab	ns	4	4	ns	0	0	ns	ns	ns	ns	ns	ns	ns	ns	8/16
M. hyopneumoniae	Nasal swab	0	ns	0	0	0	ns	0	ns	2	2	4	4	3	4	19/44
B. bronchiseptica	Nasal swab	ns	4	4	4	4	4	ns	ns	ns	ns	ns	ns	ns	ns	20/20